Teva Beats Pfizer to Win Ratiopharm for $5 Billion

David Fox and Volker Kullmann led Teva Pharmaceutical Industries in an EUR3.625 billion acquisition of German generics producer Ratiopharm.

To read the full text of the article, please click here.